$EBS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Emergent BioSolutions Inc.. Get notifications about new insider transactions in Emergent BioSolutions Inc. for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 21 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 15.83 | 9,773 | 154,707 | 51,217 | 41.4 K to 51.2 K (+23.58 %) |
Jun 17 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 31.50 | 15,919 | 501,480 | 41,444 | 57.4 K to 41.4 K (-27.75 %) |
Jun 17 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 14.67 | 15,919 | 233,532 | 57,363 | 41.4 K to 57.4 K (+38.41 %) |
Jun 15 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 32.00 | 368 | 11,776 | 1,950,196 | 2 M to 2 M (-0.02 %) |
Jun 15 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 32.03 | 15,068 | 482,630 | 1,950,564 | 2 M to 2 M (-0.77 %) |
Jun 15 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 32.26 | 30,000 | 967,923 | 1,965,632 | 2 M to 2 M (-1.50 %) |
Jun 02 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | P | 27.08 | 98 | 2,654 | 41,444 | 41.3 K to 41.4 K (+0.24 %) |
May 28 2015 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 30.54 | 500 | 15,272 | 16,450 | 17 K to 16.5 K (-2.95 %) |
May 21 2015 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Grant | A | 0.00 | 9,400 | 0 | 16,950 | 7.6 K to 17 K (+124.50 %) |
May 21 2015 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Grant | A | 0.00 | 9,400 | 0 | 30,300 | 20.9 K to 30.3 K (+44.98 %) |
May 21 2015 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Grant | A | 0.00 | 9,400 | 0 | 28,500 | 19.1 K to 28.5 K (+49.21 %) |
May 21 2015 | EBS | Emergent BioSoluti ... | Niederhuber John | Director | Grant | A | 0.00 | 9,400 | 0 | 30,300 | 20.9 K to 30.3 K (+44.98 %) |
May 21 2015 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Grant | A | 0.00 | 9,400 | 0 | 19,500 | 10.1 K to 19.5 K (+93.07 %) |
May 21 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Grant | A | 0.00 | 9,400 | 0 | 28,500 | 19.1 K to 28.5 K (+49.21 %) |
May 21 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 9,400 | 0 | 28,500 | 19.1 K to 28.5 K (+49.21 %) |
May 21 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Grant | A | 0.00 | 9,400 | 0 | 28,500 | 19.1 K to 28.5 K (+49.21 %) |
May 15 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Gift | G | 0.00 | 936 | 0 | 183,869 | 184.8 K to 183.9 K (-0.51 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | M | 14.25 | 2,400 | 34,200 | 4,800 | |
May 14 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | M | 14.66 | 4,800 | 70,368 | 2,400 | |
May 14 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | M | 11.67 | 13,600 | 158,712 | 0 | |
May 14 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 30.01 | 2,400 | 72,024 | 19,100 | 21.5 K to 19.1 K (-11.16 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | M | 14.25 | 2,400 | 34,200 | 21,500 | 19.1 K to 21.5 K (+12.57 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 30.01 | 4,800 | 144,048 | 19,100 | 23.9 K to 19.1 K (-20.08 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | M | 14.66 | 4,800 | 70,368 | 23,900 | 19.1 K to 23.9 K (+25.13 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 30.09 | 13,600 | 409,224 | 19,100 | 32.7 K to 19.1 K (-41.59 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | M | 11.67 | 13,600 | 158,712 | 32,700 | 19.1 K to 32.7 K (+71.20 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 16.13 | 1,440 | 23,227 | 5,760 | |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 11.67 | 5,760 | 67,219 | 8,640 | |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 8.76 | 6,960 | 60,970 | 4,640 | |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 8.43 | 5,760 | 48,557 | 1,440 | |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 30.16 | 1,440 | 43,430 | 19,100 | 20.5 K to 19.1 K (-7.01 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 16.13 | 1,440 | 23,227 | 20,540 | 19.1 K to 20.5 K (+7.54 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 30.08 | 5,760 | 173,261 | 19,100 | 24.9 K to 19.1 K (-23.17 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 11.67 | 5,760 | 67,219 | 24,860 | 19.1 K to 24.9 K (+30.16 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 30.13 | 6,960 | 209,705 | 19,100 | 26.1 K to 19.1 K (-26.71 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 8.76 | 6,960 | 60,970 | 26,060 | 19.1 K to 26.1 K (+36.44 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 30.14 | 5,760 | 173,606 | 19,100 | 24.9 K to 19.1 K (-23.17 %) |
May 14 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 8.43 | 5,760 | 48,557 | 24,860 | 19.1 K to 24.9 K (+30.16 %) |
Mar 13 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 28.99 | 72,413 | 2,099,253 | 72,413 | |
Mar 13 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 28.67 | 1,463 | 41,944 | 1,995,632 | 2 M to 2 M (-0.07 %) |
Mar 13 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 28.99 | 1,906 | 55,255 | 1,997,095 | 2 M to 2 M (-0.10 %) |
Mar 13 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 29.00 | 5,128 | 148,712 | 1,999,001 | 2 M to 2 M (-0.26 %) |
Mar 13 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Grant | A | 0.00 | 36,219 | 0 | 2,004,129 | 2 M to 2 M (+1.84 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | A | 28.99 | 21,517 | 623,778 | 21,517 | |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Payment of Exercise | F | 29.00 | 1,594 | 46,226 | 36,793 | 38.4 K to 36.8 K (-4.15 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Grant | A | 0.00 | 10,762 | 0 | 38,387 | 27.6 K to 38.4 K (+38.96 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | A | 28.99 | 18,620 | 539,794 | 18,620 | |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 28.67 | 785 | 22,506 | 41,073 | 41.9 K to 41.1 K (-1.88 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 28.99 | 1,278 | 37,049 | 41,858 | 43.1 K to 41.9 K (-2.96 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 29.00 | 1,535 | 44,515 | 43,136 | 44.7 K to 43.1 K (-3.44 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Grant | A | 0.00 | 9,313 | 0 | 44,671 | 35.4 K to 44.7 K (+26.34 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Option Exercise | A | 28.99 | 33,017 | 957,163 | 33,017 | |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Payment of Exercise | F | 28.99 | 422 | 12,234 | 71,112 | 71.5 K to 71.1 K (-0.59 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Payment of Exercise | F | 29.00 | 2,818 | 81,722 | 71,534 | 74.4 K to 71.5 K (-3.79 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Grant | A | 0.00 | 16,514 | 0 | 74,352 | 57.8 K to 74.4 K (+28.55 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | A | 28.99 | 94,344 | 2,735,033 | 94,344 | |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 28.67 | 4,490 | 128,728 | 184,805 | 189.3 K to 184.8 K (-2.37 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 28.99 | 6,493 | 188,232 | 189,295 | 195.8 K to 189.3 K (-3.32 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 29.00 | 9,779 | 283,591 | 195,788 | 205.6 K to 195.8 K (-4.76 %) |
Mar 12 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Grant | A | 0.00 | 47,188 | 0 | 205,567 | 158.4 K to 205.6 K (+29.79 %) |
Jan 23 2015 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Option Exercise | A | 27.93 | 14,100 | 393,813 | 14,100 | |
Jan 23 2015 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Grant | A | 0.00 | 7,050 | 0 | 7,550 | 500 to 7.6 K (+1,410.00 %) |
Jan 21 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 7.00 | 33,333 | 233,331 | 0 | |
Jan 21 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 28.24 | 7,303 | 206,232 | 1,967,910 | 2 M to 2 M (-0.37 %) |
Jan 21 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 27.16 | 8,022 | 217,853 | 1,975,213 | 2 M to 2 M (-0.40 %) |
Jan 21 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 7.00 | 33,333 | 233,331 | 1,983,235 | 1.9 M to 2 M (+1.71 %) |
Dec 29 2014 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Payment of Exercise | F | 24.41 | 1,577 | 38,495 | 27,625 | 29.2 K to 27.6 K (-5.40 %) |
Dec 29 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 15.91 | 6,285 | 99,994 | 38,006 | |
Dec 29 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 18.90 | 5,291 | 100,000 | 63,209 | |
Dec 29 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 27.64 | 7,236 | 200,003 | 158,379 | 165.6 K to 158.4 K (-4.37 %) |
Dec 29 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 15.91 | 6,285 | 99,994 | 165,615 | 159.3 K to 165.6 K (+3.94 %) |
Dec 29 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 18.90 | 5,291 | 100,000 | 159,330 | 154 K to 159.3 K (+3.43 %) |
Dec 29 2014 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 2.74 | 5,000 | 13,700 | 0 | |
Dec 29 2014 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 28.00 | 5,000 | 140,000 | 19,100 | 24.1 K to 19.1 K (-20.75 %) |
Dec 29 2014 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 2.74 | 5,000 | 13,700 | 24,100 | 19.1 K to 24.1 K (+26.18 %) |
Dec 19 2014 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 2.74 | 5,000 | 13,700 | 0 | |
Dec 19 2014 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 27.00 | 5,000 | 135,000 | 19,100 | 24.1 K to 19.1 K (-20.75 %) |
Dec 19 2014 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 2.74 | 5,000 | 13,700 | 24,100 | 19.1 K to 24.1 K (+26.18 %) |
Dec 11 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 26.00 | 68,413 | 1,778,738 | 1,949,902 | 2 M to 1.9 M (-3.39 %) |
Dec 11 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 26.00 | 416 | 10,816 | 2,018,315 | 2 M to 2 M (-0.02 %) |
Dec 11 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 26.00 | 50,512 | 1,313,312 | 2,018,731 | 2.1 M to 2 M (-2.44 %) |
Dec 01 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 25.00 | 13,597 | 339,925 | 0 | 13.6 K to 0 (-100.00 %) |
Dec 01 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 25.00 | 5,135 | 128,375 | 0 | 5.1 K to 0 (-100.00 %) |
Dec 01 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 25.00 | 14,355 | 358,875 | 0 | 14.4 K to 0 (-100.00 %) |
Dec 01 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 25.00 | 1,490 | 37,250 | 14,355 | 15.8 K to 14.4 K (-9.40 %) |
Nov 26 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 25.00 | 2,126 | 53,150 | 5,135 | 7.3 K to 5.1 K (-29.28 %) |
Nov 26 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 25.00 | 500 | 12,500 | 13,597 | 14.1 K to 13.6 K (-3.55 %) |
Nov 26 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 25.00 | 6,388 | 159,700 | 7,261 | 13.6 K to 7.3 K (-46.80 %) |
Nov 25 2014 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | M | 11.67 | 8,000 | 93,360 | 13,600 | |
Nov 25 2014 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Sell | S | 24.82 | 8,000 | 198,560 | 19,100 | 27.1 K to 19.1 K (-29.52 %) |
Nov 25 2014 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Buy | M | 11.67 | 8,000 | 93,360 | 27,100 | 19.1 K to 27.1 K (+41.88 %) |
Nov 14 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 25.00 | 115 | 2,875 | 14,097 | 14.2 K to 14.1 K (-0.81 %) |
Nov 14 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 25.00 | 2,196 | 54,900 | 13,649 | 15.8 K to 13.6 K (-13.86 %) |
Nov 12 2014 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP & CFO | Sell | S | 24.00 | 2,625 | 63,000 | 57,838 | 60.5 K to 57.8 K (-4.34 %) |
Nov 12 2014 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP & CFO | Payment of Exercise | F | 22.31 | 1,238 | 27,620 | 60,463 | 61.7 K to 60.5 K (-2.01 %) |
Oct 16 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Grant | A | 18.44 | 290 | 5,348 | 35,358 | 35.1 K to 35.4 K (+0.83 %) |
Oct 16 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Grant | A | 18.44 | 506 | 9,331 | 154,039 | 153.5 K to 154 K (+0.33 %) |
Sep 03 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 25.00 | 1,633 | 40,825 | 14,212 | 15.8 K to 14.2 K (-10.31 %) |
Aug 27 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 25.00 | 70,769 | 1,769,225 | 2,069,243 | 2.1 M to 2.1 M (-3.31 %) |
May 23 2014 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Option Exercise | A | 20.44 | 9,400 | 192,136 | 9,400 | |
May 23 2014 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Grant | A | 0.00 | 4,700 | 0 | 20,900 | 16.2 K to 20.9 K (+29.01 %) |
May 23 2014 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | A | 20.44 | 9,400 | 192,136 | 9,400 | |
May 23 2014 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Grant | A | 0.00 | 4,700 | 0 | 19,100 | 14.4 K to 19.1 K (+32.64 %) |
May 23 2014 | EBS | Emergent BioSoluti ... | Niederhuber John | Director | Option Exercise | A | 20.44 | 9,400 | 192,136 | 9,400 | |
May 23 2014 | EBS | Emergent BioSoluti ... | Niederhuber John | Director | Grant | A | 0.00 | 4,700 | 0 | 20,900 | 16.2 K to 20.9 K (+29.01 %) |
May 23 2014 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Option Exercise | A | 20.44 | 9,400 | 192,136 | 9,400 | |
May 23 2014 | EBS | Emergent BioSoluti ... | Harsanyi Zsolt | Director | Grant | A | 0.00 | 4,700 | 0 | 19,100 | 14.4 K to 19.1 K (+32.64 %) |
May 23 2014 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Option Exercise | A | 20.44 | 9,400 | 192,136 | 9,400 | |
May 23 2014 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Grant | A | 0.00 | 4,700 | 0 | 10,100 | 5.4 K to 10.1 K (+87.04 %) |
May 23 2014 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | A | 20.44 | 9,400 | 192,136 | 9,400 | |
May 23 2014 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 4,700 | 0 | 19,100 | 14.4 K to 19.1 K (+32.64 %) |
May 23 2014 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | A | 20.44 | 9,400 | 192,136 | 9,400 | |
May 23 2014 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Grant | A | 0.00 | 4,700 | 0 | 19,100 | 14.4 K to 19.1 K (+32.64 %) |
Apr 17 2014 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Sell | S | 24.36 | 47,689 | 1,161,704 | 62,183 | 109.9 K to 62.2 K (-43.40 %) |
Apr 17 2014 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Sell | S | 24.00 | 2,500 | 60,000 | 109,872 | 112.4 K to 109.9 K (-2.22 %) |
Mar 18 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 27.06 | 1,077 | 29,144 | 35,068 | 36.1 K to 35.1 K (-2.98 %) |
Mar 18 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 27.06 | 2,248 | 60,831 | 155,533 | 157.8 K to 155.5 K (-1.42 %) |
Mar 14 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 27.06 | 3,659 | 99,013 | 2,141,275 | 2.1 M to 2.1 M (-0.17 %) |
Mar 14 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 27.15 | 1,463 | 39,720 | 2,144,934 | 2.1 M to 2.1 M (-0.07 %) |
Mar 13 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 27.15 | 3,021 | 82,020 | 157,781 | 160.8 K to 157.8 K (-1.88 %) |
Mar 13 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 18.90 | 11,562 | 218,522 | 0 | |
Mar 13 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 27.50 | 11,562 | 317,955 | 36,145 | 47.7 K to 36.1 K (-24.24 %) |
Mar 13 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 18.90 | 11,562 | 218,522 | 47,707 | 36.1 K to 47.7 K (+31.99 %) |
Mar 13 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 27.15 | 775 | 21,041 | 36,145 | 36.9 K to 36.1 K (-2.10 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 28.09 | 112,479 | 3,159,535 | 112,479 | |
Mar 12 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 28.09 | 1,887 | 53,006 | 2,144,510 | 2.1 M to 2.1 M (-0.09 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Grant | A | 0.00 | 56,240 | 0 | 2,146,397 | 2.1 M to 2.1 M (+2.69 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | A | 28.09 | 28,119 | 789,863 | 28,119 | |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Grant | A | 28.09 | 14,060 | 394,945 | 29,202 | 15.1 K to 29.2 K (+92.85 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Option Exercise | A | 28.09 | 123,192 | 3,460,463 | 123,192 | |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Grant | A | 0.00 | 61,596 | 0 | 160,802 | 99.2 K to 160.8 K (+62.09 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Payment of Exercise | F | 28.09 | 4,347 | 122,107 | 99,206 | 103.6 K to 99.2 K (-4.20 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Option Exercise | A | 28.09 | 52,062 | 1,462,422 | 52,062 | |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Grant | A | 0.00 | 26,031 | 0 | 112,372 | 86.3 K to 112.4 K (+30.15 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 15.83 | 4,887 | 77,361 | 4,887 | |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 15.91 | 6,933 | 110,304 | 0 | |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | A | 28.09 | 28,119 | 789,863 | 28,119 | |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 26.96 | 11,820 | 318,667 | 36,920 | 48.7 K to 36.9 K (-24.25 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 15.91 | 6,933 | 110,304 | 48,800 | 41.9 K to 48.8 K (+16.56 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 15.83 | 4,887 | 77,361 | 41,807 | 36.9 K to 41.8 K (+13.24 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 26.96 | 5,835 | 157,312 | 36,920 | 42.8 K to 36.9 K (-13.65 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Grant | A | 0.00 | 14,060 | 0 | 42,755 | 28.7 K to 42.8 K (+49.00 %) |
Mar 12 2014 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 28.09 | 1,336 | 37,528 | 28,695 | 30 K to 28.7 K (-4.45 %) |
Feb 03 2014 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | A | 20.94 | 30,284 | 634,147 | 30,284 | |
Feb 03 2014 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Grant | A | 0.00 | 15,142 | 0 | 15,412 | 270 to 15.4 K (+5,608.15 %) |
Dec 09 2013 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO | Buy | P | 19.08 | 749 | 14,291 | 103,373 | 102.6 K to 103.4 K (+0.73 %) |
Nov 12 2013 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Option Exercise | M | 10.13 | 4,613 | 46,730 | 0 | |
Nov 12 2013 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | CEO & President | Buy | M | 10.13 | 4,613 | 46,730 | 100,624 | 96 K to 100.6 K (+4.80 %) |
Nov 06 2013 | EBS | Emergent BioSoluti ... | Kramer Robert | CFO | Payment of Exercise | F | 19.58 | 1,219 | 23,868 | 86,341 | 87.6 K to 86.3 K (-1.39 %) |
Jul 18 2013 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Option Exercise | A | 17.51 | 10,800 | 189,108 | 10,800 |